Al Gianchetti
Drug Development and Commercialization Strategy Ad
Pharmaceutical Science
KBP BioSciences
United States of America
Biography
Al Gianchetti is President and CEO of Longview Biopharm Partners. He has over 25 years of experience in biopharmaceuticals in both R&D and US and global operations, including 7 years in the biotech environment and the remainder at GSK. In VP, Chief Commercial Officer and in other leadership positions, he has sat on governance boards in sales, brand management, payer and managed care, drug discovery, drug development, business and corporate development and supply chain allowing him a broad view of the business. Al was involved in development of 7 phase III programs and more than 10 phase I/II programs, led several US and global product launches and the acquisition/licensing of more than 10 products. His therapeutic experience includes infectious diseases, psychiatry and neurosciences, cardio-metabolic-renal diseases including diabetes, oncology and urologic/men’s health.
Research Interest
Pharmaceutical Science
